KRON - Kronos Bio GAAP EPS of -$0.46 misses by $0.02 revenue of $1.22M misses by $3.78M
2023-05-10 17:49:08 ET
- Kronos Bio press release ( NASDAQ: KRON ): Q1 GAAP EPS of -$0.46 misses by $0.02 .
- Revenue of $1.22M misses by $3.78M .
- Cash, Cash Equivalents and Investments: With its ongoing and currently planned clinical programs and $241.3 million in cash, cash equivalents and investments as of March 31, 2023, the company reiterates its expected cash runway into the second half of 2025.
For further details see:
Kronos Bio GAAP EPS of -$0.46 misses by $0.02, revenue of $1.22M misses by $3.78M